BioDetection Systems b.v.

BioDetection Systems b.v. (BDS) provides ultra-sensitive and cost-effective bioassays for a wide range of persistent organic pollutants (POPs) such as dioxins, PCBs or endocrine disrupters. Our analysis prices are usually ca. 60% lower than the usual chemical laboratories by using the DR CALUX technology.

Company details

Science Park 406 , Amsterdam , 1098 XH Netherlands

Locations Served

Business Type:
Industry Type:
Monitoring and Testing
Market Focus:
Globally (various continents)
Year Founded:
1,000,000 - 10,000,000 €

BioDetection Systems b.v. (BDS) is a Dutch company providing bio-based screening technologies for safety, quality and bioactivity assessment. These services are available through our own laboratories, but may also be performed under license. In addition, our knowledge, assays and facilities are available to others by means of contract research or as a project partner.

Our company is highly experienced in the sensitive detection of key organic pollutants such as dioxin(-like) compounds, PCBs, PAHs and other persistent organic pollutants (POPs). Moreover, we are equipped to detect an extensive set of biological activities in various types of samples ranging from e.g. environmental to clinical samples and from pure compounds to extremely complex mixtures.  Our assays provide meaningful information related to a.o. xenobiotic metabolism, endocrine disruption, genotoxicity, and acute toxicity.

Lead by Professor Abraham Brouwer, a recognized expert in these fields, BDS has evolved into a knowledge intensive company in the field of safety and hazard assessments as well biological functionality screenings.

To develop and provide innovative bioassays and implement their use to the highest international standards as analytical tools for safety and quality assessment of food, environment, consumer products and chemicals.

Whilst we recognize that there will be an ongoing need to test some materials in animal models, we believe that our bioassays offer biologically relevant tools and we will promote replacement of animal tests with bioassays.

We aim to achieve our goals by:

  • Developing innovative bioassays
  • Improving acceptance of bioassays
  • Launching bioassays on the market
  • Assessing environmental and human risks and benefits rapidly
  • Offering the best products and the best support service
  • Cultivating long-term partnerships with our customers